Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.

TitleApc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.
Publication TypeJournal Article
Year of Publication2015
AuthorsDow LE, O'Rourke KP, Simon J, Tschaharganeh DF, van Es JH, Clevers H, Lowe SW
JournalCell
Volume161
Issue7
Pagination1539-1552
Date Published2015 Jun 18
ISSN1097-4172
KeywordsAdenomatous Polyposis Coli Protein, Animals, Cell Proliferation, Colorectal Neoplasms, Disease Models, Animal, Doxycycline, Genes, p53, Intestinal Polyps, Intestine, Large, Intestine, Small, Mice, Mice, Transgenic, Proto-Oncogene Proteins p21(ras), RNA Interference, Wnt Signaling Pathway
Abstract

The adenomatous polyposis coli (APC) tumor suppressor is mutated in the vast majority of human colorectal cancers (CRC) and leads to deregulated Wnt signaling. To determine whether Apc disruption is required for tumor maintenance, we developed a mouse model of CRC whereby Apc can be conditionally suppressed using a doxycycline-regulated shRNA. Apc suppression produces adenomas in both the small intestine and colon that, in the presence of Kras and p53 mutations, can progress to invasive carcinoma. In established tumors, Apc restoration drives rapid and widespread tumor-cell differentiation and sustained regression without relapse. Tumor regression is accompanied by the re-establishment of normal crypt-villus homeostasis, such that once aberrantly proliferating cells reacquire self-renewal and multi-lineage differentiation capability. Our study reveals that CRC cells can revert to functioning normal cells given appropriate signals and provide compelling in vivo validation of the Wnt pathway as a therapeutic target for treatment of CRC.

DOI10.1016/j.cell.2015.05.033
Alternate JournalCell
PubMed ID26091037
PubMed Central IDPMC4475279
Grant ListCA 181280-01 / CA / NCI NIH HHS / United States
T32GM07739 / GM / NIGMS NIH HHS / United States
K22 CA181280 / CA / NCI NIH HHS / United States
F30 CA200110 / CA / NCI NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
/ / Howard Hughes Medical Institute / United States
U01 CA168409 / CA / NCI NIH HHS / United States
P01 CA013106 / CA / NCI NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
R01 CA195787 / CA / NCI NIH HHS / United States
CA-013106 / CA / NCI NIH HHS / United States

Person Type: